Searched for
INDIAN VACCINE SALES
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...
- Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Mankind Pharma profit jumps 30% on chronic therapy demand in Q4Mankind Pharma announced a significant 30 percent profit increase for the fourth quarter. This growth was fueled by strong demand for chron...
- Honesty and integrity were not enough: US-based entrepreneur Kal Somani-led group lashes Rajasthan Royals sale processA rival bidder has publicly questioned the Rajasthan Royals ownership sale process. The US-based entrepreneur Kal Somani and his partners e...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- Global companies account for 60% of Indian vaccine sales by valueIndia's vaccine market is steadily recovering after the impact from Covid-19 and multinationals are back to slowly gaining traction, sugges...
- Bharat Biotech says supply chains not impacted by Russia-Ukraine conflictIndian vaccine maker Bharat Biotech said on Friday that the Russia-Ukraine conflict had not impacted the company's supply chains so far.
- Bharat Biotech ties up with Ocugen to commercialise Covaxin in CanadaUnder the agreement, Ocugen will have the US rights to the vaccine candidate and will be responsible for clinical development, regulatory a...
- Supreme Court notice to Government on PIL over marketing of Gardasil and Crevarix vaccinesGardasil and Crevarix, both human papilloma virus (HPV) vaccines, are being marketed in India by MSD Pharmaceutical.
- India emerging as leading vaccine manufacturer: Steven MyintIndia had revenue of $ 665 million in this space which was expected to reach $ 800 million soon, said Steven H Myint.
- Sanofi-Aventis buys Shantha for Rs 3,740 crThe deal between Sanofi its French owners Meriuex Alliance values the unlisted Indian company at Rs 3,740 crore, or about eight times its p...
- Indian vaccine cos want a slice of US pieIndian vaccine makers are setting their sights on tapping the growing US market after the Obama administration committed $300 million for i...
- Panacea bags $35-m deal from UnicefPanacea Biotec is learnt to have bagged a $35-million drug supply order from UNICEF to supply pentavalent vaccines, the first Indian compan...
Load More
